Discover why structured clinical trial data services and clinical trials solutions are now critical for pharma R&D, BD teams, and CROs competing in a complex drug development landscape.
Discover how Clinical Trial Intelligence is transforming the clinical drug development process, improving drug development decisions, and supporting smarter API drug development with real-time data and AI-driven insights.
Learn how better data helps pharmaceutical companies identify the right drug licensing opportunities through clinical drug development, development of drug insights, and API drug development intelligence.
The rate of innovation is impressive both in terms of the opportunities it offers, and in terms of the complexity with which strategic decisions have to be made.
Discover how Predictive Clinical Intelligence, AI, and real-time analytics are transforming clinical drug research, drug development clinical trial phases, and the phases of drug development to help pharmaceutical companies make faster, smarter decisions.
It's the structured path a molecule follows from lab to market: preclinical research, Phase I (safety), Phase II (efficacy and dosing), Phase III (large-scale confirmation), regulatory review, and Phase IV post-market monitoring. As of 2026, nearly half of the roughly 23,000 active global pipeline drugs are still in the preclinical stage alone.
Discover how AI, real-time API intelligence, phases of pharmaceutical development, and API clinical trial data are transforming pharmaceutical supply chains through smarter forecasting, risk management, and strategic decision-making.
Learn how predictive supplier insights help prevent API shortages by identifying risks early, improving sourcing decisions, and ensuring supply continuity.
Here is a number that should stop you: more than 10,000 rare diseases have been identified globally, yet fewer than 500 have an approved treatment.
This is why more pharmaceutical companies are investing in unified intelligence platforms that centralize data, improve visibility, and support better decision-making across the drug development lifecycle.
30 July 2026
29 July 2026
29 July 2026
20 July 2026
20 July 2026
